Market Research Logo

Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2018-2022)

Global In-Vitro Diagnostics (IVD) Market: Industry Analysis & Outlook (2018-2022)

Diagnosis is the identification of the nature and cause of a certain phenomenon. It involves two different types of testing method: in vivo and in vitro diagnostics. In-vitro diagnostics (IVDs) tests are defined as tests executed outside a patient’s body which put analytical instruments, devices, reagents, calibrators and systems to use for checking of health status or diagnosing diseases.

The global IVD market is experiencing a lucrative growth due to rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, increasing adoption of fully-automated instruments and automation in laboratories, increasing adoption of point-of-care testing, and growing awareness of personalized medicine. Also, there are various companies developing syndromic testing panels and using human microbiomes in the IVD.

On the basis of technology, the global IVD market remained dominated by immunodiagnostics and blood glucose self-monitoring segments owing to the strong base of older population and diabetic population. On product basis, the reagents acquired a major share in the global IVD market, followed by instruments. Instruments segment would hold a higher share in the coming years due to increasing demand of personalized medicines among patients.

Regionally, North America contributed a major chunk to the global IVD market primarily due to recent introduction of new novel reagents and wide availability of effective and cost-efficient reagents. However, Asia-Pacific region is holding the highest growth rate due to swiftly growing economies of India and China, increase in gross domestic product, and the rising disposable income.

The competitive landscape of global IVD market is quite consolidated with four key players including Siemens AG, Danaher Corporation, Roche Holding, and Abbott Laboratories. Due to the strong presence of these companies in the market, new entrants might find it difficult to penetrate the market with their products.


1. Overview
1.1 In-Vitro Diagnostics (IVD)
Table 1: Types of Diagnostics
1.2 IVD Product by Types
Table 2: Types of IVD Products
1.3 IVD Tests
Table 3: Types of IVD Tests
1.4 IVD Market by Technology
Table 4: IVD Market by Technology
1.5 IVD Uses
1.6 IVD Value Chain Analysis
Table 5: IVD Value Chain Analysis
2. Global IVD Market
2.1 Global IVD Market Forecast by Value
Table 6: Global IVD Market Forecast by Value (2017-2022)
2.2 Global IVD Market by Region
Table 7: Global IVD Market by Region (2017)
2.3 Global IVD Market by End Users
Table 8: Global IVD Market by End Users (2017)
2.4 Global IVD Market by Product
Table 9: Global IVD Market by Product (2017)
2.4.1 Global IVD Reagents Market Forecast by Value
Table 10: Global IVD Reagents Market Forecast by Value (2017-2022)
2.4.2 Global IVD Instrument Market Forecast by Value
Table 11: Global IVD Instrument Market Forecast by Value (2017-2022)
2.5 Global IVD Market by Technology
Table 12: Global IVD Market by Technology (2017)
2.5.1 Global Immunodiagnostics Market Forecast by Value
Table 13: Global Immunodiagnostics Market Forecast by Value (2017-2022)
2.5.2 Global Immunodiagnostics Market by Indications
Table 14: Global Immunodiagnostics Market by Indications (2017)
2.5.3 Global Molecular Diagnostics Market Forecast by Value
Table 15: Global Molecular Diagnostics Market Forecast by Value (2017-2022)
2.5.4 Global Molecular Diagnostics Market by Indications
Table 16: Global Molecular Diagnostics Market by Indications (2017)
2.5.5 Global Hematology Market Forecast by Value
Table 17: Global Hematology Market Forecast by Value (2017-2022)
2.5.6 Global Point Of Care (POC) Market Forecast by Value
Table 18: Global Point Of Care (POC) Market Forecast by Value (2017-2022)
2.5.7 Global Point Of Care (POC) Market by Type
Table 19: Global Point Of Care (POC) Market by Type (2017)
2.5.8 Global Clinical Chemistry Market Forecast by Value
Table 20: Global Clinical Chemistry Market Forecast by Value (2017-2022)
2.5.9 Global Microbiology Market Forecast by Value
Table 21: Global Microbiology Market Forecast by Value (2017-2022)
2.5.10 Global SMBG Market Forecast by Value
Table 22: Global SMBG Market Forecast by Value (2017-2022)
3. Regional IVD Market
3.1 North America
3.1.1 North America IVD Market Forecast by Value
Table 23: North America IVD Market Forecast by Value (2017-2022)
3.1.2 The US IVD Market Forecast by Value
Table 24: The US IVD Market Forecast by Value (2017-2022)
3.2 EMEA
3.2.1 EMEA IVD Market Forecast by Value
Table 25: EMEA IVD Market Forecast by Value (2017-2022)
3.3 Asia-Pacific
3.3.1 Asia-Pacific IVD Market Forecast by Value
Table 26: Asia-Pacific IVD Market Forecast by Value (2017-2022)
3.3.2 China IVD Market Forecast by Value
Table 27: China IVD Market Forecast by Value (2017-2022)
3.3.3 Japan IVD Market Forecast by Value
Table 28: Japan IVD Market Forecast by Value (2017-2022)
3.3.4 Australia IVD Market Forecast by Value
Table 29: Australia IVD Market Forecast by Value (2017-2022)
3.3.5 India IVD Market Forecast by Value
Table 30: India IVD Market Forecast by Value (2017-2022)
3.4 Latin America
3.4.1 Latin America IVD Market Forecast by Value
Table 31: Latin America IVD Market Forecast by Value (2017-2022)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Diabetic Patient Base
Table 32: Global Diabetes Patient Volume Forecast (2014/2035)
4.1.2 Surge in Incidences of Chronic Ailments
Table 33: Global New Cancer Patients Volume (2013-2017)
4.1.3 Increasing Global Healthcare Expenditure
Table 34: Global Healthcare Expenditure Per Capita (2013-2017)
4.1.4 Increasing Disposable Income
Table 35: Global GNI per Capita (2013-2017)
4.1.5 Growing Geriatric Population
Table 36: Global Population above 64 Years (2013-2017)
4.2 Key Trends & Developments
4.2.1 Development of Syndromic Panel
4.2.2 Liquid Biopsy for Cancer Testing
4.2.3 Applications of Human Microbiome in IVD
4.3 Challenges
4.3.1 Government Regulation for IVD Tests
5. Competitive Landscape
5.1 Global IVD Market
5.1.1 Revenue and Market Cap. Comparison
Table 37: Revenue and Market Cap. Comparison by Company (2017)
5.1.2 Global IVD Market Share by Company
Table 38: Global IVD Market Share by Company (2017)
5.1.3 Global Molecular Diagnostics Market Share by Company
Table 39: Global Molecular Diagnostics Market Share by Company (2017)
5.1.4 Global Immunodiagnostics Market Share by Company
Table 40: Global Immunodiagnostics Market Share by Company (2017)
5.1.5 Global POCT Market Share by Company
Table 41: Global POCT Market Share by Company (2017)
6. Company Profiles
6.1 Siemens AG
6.1.1 Business Overview
Table 42: Siemens AG Revenue by Segment (2017)
6.1.2 Financial Overview
Table 43: Siemens AG Revenue and Net Income (2013-2017)
6.1.3 Business Strategies
Table 44: Siemens R&D Expenditure (2015-2017)
6.2 Roche Holding AG
6.2.1 Business Overview
Table 45: Roche Sales by Segments (2017)
6.2.2 Financial Overview
Table 46: Roche Sales and Net Income (2013-2017)
6.2.3 Business Strategies
Table 47: Roche Agreements (2017/2018)
Table 48: Roche Product Approvals (2018)
6.3 Abbott Laboratories
6.3.1 Business Overview
Table 49: Abbott Laboratories Sales by Segment (2017)
6.3.2 Financial Overview
Table 50: Abbott Laboratories Net Sales and Net Earnings (2013-2017)
6.3.3 Business Strategies
Table 51: Abbott Laboratories R&D Expenditure (2015-2017)
6.4 Danaher Corporation
6.4.1 Business Overview
Table 52: Danaher Corp. Revenue by Segments (2017)
6.4.2 Financial Overview
Table 53: Danaher Corp. Revenue and Net Earnings (2013-2017)
6.4.3 Business Strategies
Table 54: Danaher Corp. R&D Expenditure (2014-2016)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report